Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences, UCSF
Member, UCSF Biomedical Sciences Program (BMS) and Herbert Boyer Program in Biological Sciences (PIBS)
| CONTACT | |
|
jim.wells@ucsf.edu Box 2330, UCSF; San Francisco, CA 94158-2330 |
| EDUCATION | |
|
University of California, Berkeley, CA, B.A., 1973, Biochemistry
|
|
| PROFESSIONAL EXPERIENCE | |
|
1982-1986 |
Scientist, Genentech, Inc., Dept. of Protein Engineering |
|
1986-1989 |
Senior Scientist, Genentech, Inc., Dept. of Protein Engineering |
|
1989-1998 |
Staff Scientist, Genentech, Inc., Dept. of Protein Engineering |
|
1988-2005 |
Adjunct Asst, Assoc, and Full Professor, University of California, San Francisco, Dept. of Pharmaceutical Chemistry |
|
1998-2005 |
President and CSO, Sunesis Pharmaceuticals |
|
2005-present |
Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences, University of California, San Francisco |
|
2005-present |
Director, Small Molecule Discovery Center, University of California, San Francisco |
| HONORS & AWARDS | |
|
1979- 1981 |
Damon M. Runyon - Walter Winchell Postdoctoral Fellowship |
|
1990 |
Pfizer Award (given by the American Chemical Society for achievements in enzyme chemistry) |
|
1998 |
Recipient of the Christian B. Anfinsin Award presented by the Protein Society |
|
1998 |
Recipient of the Vincent du Vignead Award given by the American Peptide Society |
|
1999 |
Elected Member to the National Academy of Sciences |
|
2003 |
Recipient of the Hans Neurath Award given by the Protein Society |
|
2006 |
Perlman Lecture Award of the ACS biotechnology Division |
| SELECTED PUBLICATIONS | |
|
(selected from a total of 134) | |
|
Atwell, S.A., Ridgway, J.B.B., Wells, J.A. and Carter, P.J. (1997) J.Mol.Biol. 270, 26-35. "Stable Heterodimers from Remodeling the Domain Interface of a Homodimer using a Phage Display Library". | |
|
Baca, M., Presta, L.G., O'Connor, S. and Wells, J.A. (1997) J. Biol. Chem. 272, 10678-10684. "Antibody Humanization Using Monovalent Phage Display". | |
|
Ballinger, M. and Wells, J.A. (1998) Handbook of Proteases, Academic Press, Eds. Barrett, A., Rawlings, N.D. and Woessner, J.F., pp 289-294. "Subtilisin". | |
|
Braisted, A., Judice, K. and Wells, J.A. (1997) Methods in Enzymology Vol. 289 (in press) "Assembly of Proteins with Subtiligase". | |
|
Scheidig, A., Hynes, T. Pellitier, L., Wells, J.A. and Kossiakoff, A.A. (1997) Protein Science 6, 1806-1824. "Crystal Structures of Bovine Chymotrypsin and Trypsin Complexed to the Inhibitor Domain of Alzheimer's Amyloid -Protein Precursor (APPI) and Basic Pancreatic Trypsin Inhibitor (BPTI): Engineering of Inhibitors with Altered Specificities".". | |
|
Pearce, K.H., Potts, B.J., Presta, L.G., Bald, L.N., Fendly, B.M. and Wells, J.A. (1997). J. Biol. Chem. 272, 20595-20602. "Mutational Analysis of Thrombopoietin for Identification of Receptor and Neutralizing Antibody Sites". | |
|
Muller, Y.A., Li, B., Christinger, H.W., Wells, J.A., Cunningham, B.C. and De Vos, A.M. (1997) Proc. Natl. Acad. Sci. USA 94, 7192-7197. "Vascular Endothelial Growth Factor: Crystal Structure and Functional Mapping of the Kinase Domain Receptor Binding Site". | |
|
Ellman, J., Stoddard, B., and Wells, J.A. (1997) Proc. Natl. Acad. Sci. USA 94, 2779-2782. "Combinatorial Thinking in Chemistry and Biology". | |
|
Baca, M., Scanlan, T.S., Stephenson, R.C. and Wells, J.A. (1997) Proc. Natl. Acad. Sci. USA 94, 10063-10068. "Phage Display of a Catalytic Antibody to Optimize Affinity for Transition-State Analog Binding". | |
|
Atwell, S., Ultsch, M., De Vos, A.M. and Wells, J.A. (1997) Science 278, 1124-1127 "Structural Plasticity in a Remodeled Protein-Protein Interface" | |
|
Cunningham, B.C. and Wells, J.A. (1997) Current Opinion in Structural Biology 7, 457-462. "Minimized Proteins". | |
|
Starovasnik, M., Braisted, A. and Wells J.A. (1997) Proc. Natl. Acad. Sci. USA 94, 10080-10085. "Structural Mimicry of a Native Protein by a Minimized Binding Domain". | |
|
Wiesmann, C., Fuh, G., Christinger, H.W., Eigenbrot, C., Wells, J.A., De Vos, A.M. (1997) Cell 91, 695-704. "Crystal Structure at 1.7 resolution of VEGF in Complex with Domain 2 of the Flt-1 Receptor". | |
|
Fuh, G., Li, B., Crowley, C., Cunningham, B.C. and Wells, J.A. (1998) J. Biol. Chem. 273, 11197-11204. "Requirements for Binding and Signaling of the Kinase Domain Receptor for Vascular Endothelial Growth Factor". | |
|
Jones, J.T., Ballinger, M.D., Piscanne, P.I., Lofgren, J.A., Fitzpatrick, V.D., Fairbrother, W.J., Wells, J.A. and Sliwkowski, M.X. (1998) J. Biol. Chem. 273, 11667-11674. "Binding Interaction of the Heregulin- EGF-domain with ErbB3 and ErbB4 Receptors Assessed by Alanine-Scanning Mutagenesis". | |
|
Ballinger, M.D., Jones, J.T., Lofgren, J.A., Fairbrother, W.J., Akita, R.W., Sliwkowski, M.X. and Wells, J.A. (1998) J. Biol. Chem. 273, 11675-11684. "Selection of Heregulin Variants Having Higher Affinity for the ErbB3 Receptor by Monovalent Phage Display". | |
|
Pearce, K.H. and Wells, J.A. (1998) in Human Growth Hormone: Basic and Clinical Research. Human Growth Hormone: Basic and Clinical Research. Humana Press, Inc pp131-143 Activation of the Human Growth Hormone Receptor: Structure and Function of the Ligand-Receptor Complex". | |
|
Clackson, T., Ultsch, M., Wells, J.A. and De Vos, A.A. (1998) J. Mol. Biol. 277, 1111-1128. Structural and Functional Analysis of the 1:1 Growth Hormone:Receptor Complex Reveals the Molecular Basis for Receptor Affinity". | |
|
Ballinger, M.D. and Wells, J.A. (1998) Nature Struct. Biol. 5, 938-940. Will Any Dimer Do?" News and Views. | |
|
Erlanson, D.A. and Wells, J.A. (1998) Tet. Lett., 39, 6799-6802. Facile Synthesis of Cyclic Peptides Containing Di-, Tri-, Tetra- and Pentasulfides". | |
|
Fairbrother, W.J., Christinger, H.W., Cochran, A.G., Fuh, G., Keenan, C.J., Quan, C., Schriver, S.K., Tom, J.Y.K., Wells, J.A. and Cunningham, B.C. (1998) Biochemistry 37, 17754-17764. Novel Peptides Selected to Bind Vascular Endothelial Growth Factor Target the Receptor-Binding Site". | |
|
Arkin, M.R. and Wells, J.A. (1998) J. Mol. Biol. 284, 1083-1094. Probing the Importance of Second Sphere Residues in an Esterolytic Antibody by Phage Display". | |
|
Pearce, K.H., Cunningham, B.C., Fuh, G., Teeri, T. and Wells, J.A. (1999) Biochemistry 38, 81-89. Growth Hormone Binding Affinity for Its Receptor Surpasses the Requirements for Cellular Activity". | |
|
Atwell, S. and Wells, J.A. (1999) Proc. Natl. Acad. Sci USA 96, 9497-9502. "Selection for Improved Subtiligases by Phage Display". | |
|
Sidhu, S.S., Lowman, H.B., Cunningham, B.C. and Wells, J.A. (2000) Methods in Enzymology, Vol. 328. 333-363. "Phage Display for Selection of Novel Binding Peptides". | |
|
Sidhu, S.S., Weiss, G.A. and Wells, J.A. (2000) J. Mol. Biol. 296, 487-495. "High Copy Display of Large Proteins on M13 Phage for Functional Selections". | |
|
DeLano, W.L., Ultsch, M.H., De Vos, A.M. and Wells, J.A. (2000) Science 287, 1279-1283. "Convergent Solutions to Binding at a Protein-Protein Interface". | |
|
Weiss, G.A., Wells, J.A. and Sidhu, S.S. (2000) Protein Science 9, 647-654. "Mutational Analysis of the Major Coat Protein of M13 Identifies Residues that Control Protein Display" | |
|
Erlanson, D.A., Braisted, A.C., Raphael, D.R., Randal, M., Stroud, R.M., Gordon, E.M. and Wells, J.A. (2000) Proc. Natl. Acad. Sci. USA 97, 9367-9372. "Site-Directed Ligand Discovery". | |
|
Arkin, M.R., Randal, M., DeLano, W., Hyde, J., Loung, T.N., Oslob, J.D., Raphael, D.R., Taylor, L., Wang, J., McDowell, R.S., Wells, J.A., Braisted, A.C. (2003) Proc. Natl. Acad. Sci USA 100, 1603-1608. "Binding of Small Molecules to an Adaptive Protein:Protein Interface". | |
|
Nguyen, J. and Wells, J.A. (2003) Proc. Natl. Acad. Sci USA, 100, 7533-7538. "Direct Activation of the Apoptosis Machinery as a Mechanism to target Cancer Cells". | |
|
Thanos, C.D., Randal, M., and Wells, J.A. (2003) J. Am. Chem. Soc., 125, 15280-15281. "Potent Small-molecule Binding to a Dynamic Hot-spot on IL-2". | |
|
Stroud, R.M. and Wells, J.A. (2004) Science STKE, 2004, re7. "Mechanistic Diversity of Cytokine Signaling Across Cell Membranes" | |
|
Arkin, M.R. and Wells, J.A. (2004) Nature Rev. Drug Disc. 3, 301-317. "Small Molecule Inhibitors of Protein-Protein Interactions: Progressing Towards the Dream" | |
|
Erlanson, D.A., Wells, J.A. and Braisted, A.B. (2004) Annu. Rev. Biophys. Biomol Struct. "TETHERING: Fragment-based Drug Discovery". 33, 199-233. | |
|
Hardy, J.A., Lam, J., Nguyen, J.T., O'Brien, T and Wells, J.A. (2004) Proc. Natl. Acad. Sci. USA "Discovery of an Allosteric Site in Caspases". 101, 12461-12466. | |
|
Hardy, J.A. and Wells, J.A. (2004) Current Opinion in Structural Biology 14, 706-715. "Searching for New Allosteric Sites in Enzymes" | |
|
Buck, E., Bourne, H. and Wells, J.A. (2005) J. Biol. Chem 280, 4009-4012. "Site-specific Disulfide Capture of Agonist and Antagonist Peptides to the C5a Receptor" | |
|
Buck, E. and Wells, J.A. (2005) Proc. Natl. Acad. Sci. USA 102, 2719-2724. "Disulfide Trapping to Localize Small Molecule Agonists and Antagonists for the Complement 5a Receptor" | |
|
Scheer, J., Romanowski, M. and Wells, J.A. (2006) Proc. Natl. Acad. Sci. USA 103, 7595-7600. "A Common Allosteric Site and Mechanism in Caspases" | |
|
10/3/06 |
|


